Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Cash from Operating Activities
Theravance Biopharma Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Cash from Operating Activities
-$27m
|
CAGR 3-Years
52%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
See Also
What is Theravance Biopharma Inc's Cash from Operating Activities?
Cash from Operating Activities
-27m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Cash from Operating Activities amounts to -27m USD.
What is Theravance Biopharma Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%
Over the last year, the Cash from Operating Activities growth was 86%. The average annual Cash from Operating Activities growth rates for Theravance Biopharma Inc have been 52% over the past three years , 25% over the past five years , and 14% over the past ten years .